Industry: Drug Manufacturing, Pharmaceuticals
Mylan is the first company to file a supplemental ANDA for Estradiol Transdermal Systems, 0.0375 mg/day and 0.06 mg/day, and has been awarded a 180-day period of marketing exclusivity for these two strengths. Mylan expects to launch this product shortly. Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries: Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. ( www.mylan.com )
Mylan Laboratories Inc.
1500 Corporate Drive Suite 400
Canonsburg, Pennsylvania 15317
USA
Tel: (724) 514-1800
Fax: (724) 514-1870